Clinical characteristics of MOG antibody disease: two case reports
Sign Up to like & getrecommendations! Published in 2021 at "Neurological Sciences"
DOI: 10.1007/s10072-021-05122-4
Abstract: Serum myelin oligodendrocyte glycoprotein (MOG) antibody-mediated idiopathic inflammatory demyelinating disease (IIDDs), a type of central nervous system demyelinating disease with MOG antibodies positive in serum, referred to as MOG antibody disease. This is different from… read more here.
Keywords: characteristics mog; mog antibody; disease; antibody disease ... See more keywords
The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neuro-Ophthalmology"
DOI: 10.1097/wno.0000000000001684
Abstract: Background: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is an important etiology of neurologic morbidity and specifically, atypical, and relapsing optic neuritis. This review summarizes acute treatment and long-term prevention approaches in MOGAD. Evidence Acquisition: PubMed… read more here.
Keywords: glycoprotein antibody; disease; oligodendrocyte glycoprotein; myelin oligodendrocyte ... See more keywords
Early onset calciphylaxis following acute kidney injury secondary to anti-glomerular basement membrane antibody disease
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-241265
Abstract: Calciphylaxis is commonly associated with end-stage renal disease (ESRD) and renal transplant. We present a rare case of early onset calciphylaxis in a patient presenting with acute kidney injury (AKI) secondary to anti-glomerular basement membrane… read more here.
Keywords: anti glomerular; early onset; calciphylaxis; antibody disease ... See more keywords